Patent details

EP1335987 Title: MODIFIED VACCINIA ANKARA VIRUS VARIANT

Basic Information

Publication number:
EP1335987
PCT Application Number:
PCT/EP/2001/013628
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP019917533
PCT Publication Number:
WO/2002/042480
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MODIFIED VACCINIA ANKARA VIRUS VARIANT
French Title of Invention:
VARIANT MODIFIE DU VIRUS DE LA VACCINE ANKARA
German Title of Invention:
VARIANTE DES MODIFIZIERTEN VACCINIA ANKARA VIRUS
SPC Number:
92311

Dates

Filing date:
22/11/2001
Grant date:
28/12/2005
EP Publication Date:
28/12/2005
PCT Publication Date:
30/05/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/08/2003
EP B1 Publication Date:
28/12/2005
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
22/11/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/10/2016
 
 

Name:
BAVARIAN NORDIC A/S
Address:
HEJRESKOVVEJ 10 A, 3490, KVISTGAARD, Denmark (DK)

History of Owners

From:
22/11/2001
To:
17/10/2016

Name:
Bavarian Nordic A/S
Address:
Boegeskovvej 9, 3490 Kvistgaard, Denmark (DK)

Agent

Name:
ARONOVA S.A.
From:
08/09/2016
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
MEISINGER Christine
Address:
Germany (DE)

2

Name:
CHAPLIN Paul
Address:
Germany (DE)

3

Name:
HOWLEY Paul
Address:
Germany (DE)

Priority

Priority Number:
200001764
Priority Date:
23/11/2000
Priority Country:
Denmark (DK)

Classification

Main IPC Class:
C12N 15/863;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
10/11/2020
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages